OSSF.F Stock Overview
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 3/6 |
Past Performance | 4/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Embla Medical hf. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | kr.4.50 |
52 Week High | kr.4.97 |
52 Week Low | kr.3.63 |
Beta | 0.59 |
1 Month Change | 0% |
3 Month Change | 4.65% |
1 Year Change | n/a |
3 Year Change | -36.17% |
5 Year Change | -18.18% |
Change since IPO | 12.78% |
Recent News & Updates
Recent updates
Shareholder Returns
OSSF.F | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | 1.8% | 1.2% |
1Y | n/a | -0.5% | 24.9% |
Return vs Industry: Insufficient data to determine how OSSF.F performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how OSSF.F performed against the US Market.
Price Volatility
OSSF.F volatility | |
---|---|
OSSF.F Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.2% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: OSSF.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OSSF.F's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1971 | 3,999 | Sveinn Solvason | www.ossur.com |
Embla Medical hf., together with its subsidiaries, provides non-invasive orthopedic products in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. It operates through three segments: Prosthetics, Bracing & Supports, and Patient Care. The Prosthetics segment offers mechanical products, such as lower limb prosthetics and finger prostheses; and bionic products microprocessor-controlled feet, knees, hands, liners, fingers, and other components integrated.
Embla Medical hf. Fundamentals Summary
OSSF.F fundamental statistics | |
---|---|
Market cap | US$1.88b |
Earnings (TTM) | US$56.93m |
Revenue (TTM) | US$804.32m |
33.2x
P/E Ratio2.4x
P/S RatioIs OSSF.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
OSSF.F income statement (TTM) | |
---|---|
Revenue | US$804.32m |
Cost of Revenue | US$310.36m |
Gross Profit | US$493.96m |
Other Expenses | US$437.03m |
Earnings | US$56.93m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Jul 23, 2024
Earnings per share (EPS) | 0.13 |
Gross Margin | 61.41% |
Net Profit Margin | 7.08% |
Debt/Equity Ratio | 57.4% |
How did OSSF.F perform over the long term?
See historical performance and comparison